Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FDMT compared with PCVX: revenue, margins and what each company keeps, and the suppliers and customers both name
FDMT
4D Molecular Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PCVX
Vaxcyte, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FDMT
4D Molecular Therapeutics, Inc.
vs
PCVX
Vaxcyte, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
FDMT, solid
PCVX, dashed
Supply-chain overlap
Revenue flow
FDMT: latest quarter is a loss; flow not drawable. PCVX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only FDMT
6
QURE
uniQure
customer
—
Cystic Fibrosis Foundation
unlisted
supplier
—
U.C. Berkeley
unlisted
supplier
—
University of Pennsylvania
unlisted
supplier
2 more · FDMT chain
›
Shared
0
No shared counterparties.
Only PCVX
4
TMO
Patheon Manufacturing Services LLC, part of Thermo Fisher Scientific (collectively, "Thermo Fisher")
supplier
—
Lonza
unlisted
supplier
—
Sutro Biopharma
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
University of California, San Diego
unlisted
supplier
FDMT
4D Molecular Therapeutics, Inc.
Change
11.88
▼
−7.04%
· post 11.98
Mkt cap
$858.9M
Revenue
$4M
Q2 FY26
PCVX
Vaxcyte, Inc.
Change
62.02
▼
−0.94%
· post 62.02
Closed
Oct 30 '26
Mkt cap
$9.2B
Revenue
—
vs
Compare
Closed
Oct 30 '26
FDMT
4D Molecular Therapeutics, Inc.
vs
PCVX
Vaxcyte, Inc.
11.88
▼
−7.04%
post 11.98
Price
62.02
▼
−0.94%
post 62.02
$858.9M
Mkt cap
$9.2B
Q2 FY26
$4M
Revenue
—
Change
Change
FDMT
11.88
▼
−7.04%
vs
PCVX
62.02
▼
−0.94%
Closed
Oct 30 '26